Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
123
Journal Issue
1
Pages
36
Date Issued
2024
Author(s)
Abstract
In 2020, metabolic Associated Fatty Liver Disease (MAFLD) was proposed to replace non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria. The prevalence and clinical outcomes of MAFLD subtypes remained unclear.
Subjects
Atherosclerosis; Liver fibrosis; Metabolic associated fatty liver disease; Non-alcoholic fatty liver disease; Subtype
SDGs
Type
journal article
